LiverMultiScan
Description
A noninvasive MRI scan that accurately assesses signs of liver disease, offering a complete picture of liver health through quantitative multiparametric MRI technology
Market positioning
Leading noninvasive liver assessment technology, positioned as the gold standard alternative to liver biopsy for MASLD/MASH diagnosis and monitoring
Use cases
Healthcare providers, clinicians, and patients with suspected or confirmed liver disease, particularly those with MASLD/MASH and chronic liver disease
Features
Best in class accuracy for MASH detection and stratification
Outperforms elastography with lower failure rates, especially in high BMI patients
Strong correlation with biopsy features (NAS and fibrosis)
Prognostic value for both liver and cardiovascular outcomes
Cost-effective compared to biopsy and FibroScan
No radiation exposure or contrast agents required
Standardized and reproducible metrics
Widespread insurance coverage
Compatible with existing MRI infrastructure
Pros and cons
Based on: (AI summary)
Pros
- Best in class accuracy for MASH detection and stratification
- Outperforms elastography with lower failure rates, especially in high BMI patients
- Strong correlation with biopsy features (NAS and fibrosis)
- Prognostic value for both liver and cardiovascular outcomes
- Cost-effective compared to biopsy and FibroScan
Cons
- Requires MRI access and expertise
- Higher upfront cost compared to basic blood tests
- Limited to facilities with compatible MRI equipment
- May have longer wait times due to MRI scheduling